Clinical trial
Prospective, Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer
NCT05078775 is registered in ClinicalTrials.gov with Faeth Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer
- Lead sponsor
- Faeth Therapeutics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 21, 2021
- Completion date
- July 10, 2025
- Enrollment
- 39 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced unresectable pancreatic adenocarcinoma, metastatic pancreatic adenocarcinoma